Nelson Teng

Publications

• Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma. Wender PA, Galliher WC, Bhat NM, Pillow TH, Bieber MM, Teng NN. Gynecol Oncol. 2012; 126 (1): 118-23
• The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL. Proc Natl Acad Sci U S A. 2012; 109 (17): 6662-7
• Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Urban RR, Teng NN, Kapp DS. Am J Obstet Gynecol. 2011; 204 (5): e9-e12
• Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells. Bay JM, Patterson BK, Teng NN. Infect Dis Obstet Gynecol. 2011: 2011 463081
• Prox-1, Podoplanin and HPV staining assists in identification of lymphangioma circumscriptum of the vulva and discrimination from vulvar warts. Sultan A, Dadras SS, Bay JM, Teng NN. Histopathology. 2011; 59 (6): 1274-7
• Squamous cell carcinoma arising from mature cystic teratoma of the ovary. Chiang AJ, La V, Peng J, Yu KJ, Teng NN. Int J Gynecol Cancer. 2011; 21 (3): 466-74
• The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Chiang AJ, Yu KJ, Chao KC, Teng NN. Gynecol Oncol. 2011; 121 (1): 122-5
• Wnt and hedgehog gene pathway expression in serous ovarian cancer. Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, Teng NN. Int J Gynecol Cancer. 2011; 21 (6): 975-80
• Cervical cancer screening. Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM, Lieberman RW, Lipscomb GH, Morgan M, Nava ME, Reynolds RK, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S. J Natl Compr Canc Netw. 2008; 6 (1): 58-82
• Cervical cancer. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small W, Teng N. J Natl Compr Canc Netw. 2008; 6 (1): 14-36
• Integrative proteomic and cytological analysis of the effects of extracellular Ca(2+) influx on Pinus bungeana pollen tube development. Wu X, Chen T, Zheng M, Chen Y, Teng N, Samaj J, Baluska F, Lin J. J Proteome Res. 2008; 7 (10): 4299-312
• Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults. Tran PT, Hara W, Su Z, Lin HJ, Bendapudi PK, Norton J, Teng N, King CR, Kapp DS. Int J Radiat Oncol Biol Phys. 2008; 72 (4): 1146-53
• Natural frequency analysis of tooth stability under various simulated types and degrees of alveolar vertical bone loss. Wang CH, Liu HW, Ou KL, Teng NC, Yu JJ, Huang HM. Proc Inst Mech Eng H. 2008; 222 (6): 983-9
• Ovarian cancer. Clinical practice guidelines in oncology. Morgan RJ, Alvarez RD, Armstrong DK, Boston B, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, Grigsby PW, Havrilesky LJ, Johnston C, Lancaster JM, Lele S, Matulonis U, O'Malley D, Ozols RF, Remmenga SW, Sabbatini P, Schink J, Teng N. J Natl Compr Canc Netw. 2008; 6 (8): 766-94
• Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential. Sangoi AR, Soslow RA, Teng NN, Longacre TA. Am J Surg Pathol. 2008; 32 (2): 269-74
• Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Chan JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, Teng NN, Berek JS, Osann K, Guo H. Am J Obstet Gynecol. 2008; 198 (2): 216.e1-5
• Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK. Am J Obstet Gynecol. 2008; 198 (2): 218.e1-6
• A novel technique for the enrichment of primary ovarian cancer cells. Chan JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong CS, Negrin RS. Am J Obstet Gynecol. 2007; 197 (5): 507.e1-5
• Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Hamilton CA, Kao JM, Coutre SE, Teng NN. Gynecol Oncol. 2007; 106 (2): 423-6
• Association of lymphadenectomy and survival in stage I ovarian cancer patients. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K. Obstet Gynecol. 2007; 109 (1): 12-9
• Disruption of actin filaments by latrunculin B affects cell wall construction in Picea meyeri pollen tube by disturbing vesicle trafficking. Chen T, Teng N, Wu X, Wang Y, Tang W, Samaj J, Baluska F, Lin J. Plant Cell Physiol. 2007; 48 (1): 19-30
• Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro. Bieber MM, Twist CJ, Bhat NM, Teng NN. Pediatr Blood Cancer. 2007; 48 (4): 380-6
• Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Obstet Gynecol. 2007; 109 (6): 1342-50
• Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. Tran PT, Su Z, Hara W, Husain A, Teng N, Kapp DS. Int J Radiat Oncol Biol Phys. 2007; 69 (2): 504-11
• Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K. Cancer. 2007; 109 (12): 2454-60
• Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Tran PT, Su Z, Lee P, Lavori P, Husain A, Teng N, Kapp DS. Gynecol Oncol. 2007; 105 (3): 641-9
• Prognostic factors for uterine cancer in reproductive-aged women. Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK. Obstet Gynecol. 2007; 109 (3): 655-62
• Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK. Gynecol Oncol. 2007; 104 (2): 396-400
• Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma. Zhang MM, Chan JK, Husain A, Guo HY, Teng NN. Gynecol Oncol. 2007; 105 (1): 194-8
• The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS. Br J Cancer. 2007; 96 (12): 1817-22
• Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? Chan JK, Manuel MR, Cheung MK, Osann K, Husain A, Teng NN, Rao A, Carlson RW, Whittemore AS. Gynecol Oncol. 2006; 102 (3): 508-12
• Elevated CO2 induces physiological, biochemical and structural changes in leaves of Arabidopsis thaliana. Teng N, Wang J, Chen T, Wu X, Wang Y, Lin J. New Phytol. 2006; 172 (1): 92-103
• Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Clin Cancer Res. 2006; 12 (6): 1859-67
• Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors. Zhang MM, Cheung MK, Osann K, Lee MM, Gomez SS, Whittemore AS, Husain A, Teng NN, Chan JK. Obstet Gynecol. 2006; 107 (2 Pt 1): 329-35
• Mesonephric adenocarcinoma of the cervix: a case report and review of the literature. Yap OW, Hendrickson MR, Teng NN, Kapp DS. Gynecol Oncol. 2006; 103 (3): 1155-8
• Outcomes of women with metachronous breast and ovarian carcinomas. Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK. Gynecol Oncol. 2006; 103 (1): 190-4
• Ovarian cancer in younger vs older women: a population-based analysis. Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, Teng NN, Kapp DS, Berek JS, Leiserowitz GS. Br J Cancer. 2006; 95 (10): 1314-20
• Ovarian cancer. Clinical practice guidelines in oncology. Morgan RJ, Alvarez RD, Armstrong DK, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, Johnston C, Lancaster JM, Lele S, Matulonis U, Ozols RF, Remmenga SW, Sabbatini P, Soper J, Teng N. J Natl Compr Canc Netw. 2006; 4 (9): 912-39
• Patterns and progress in ovarian cancer over 14 years. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K. Obstet Gynecol. 2006; 108 (3 Pt 1): 521-8
• Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. Chan JK, Manuel MR, Ciaravino G, Cheung MK, Husain A, Teng NN. Gynecol Oncol. 2006; 103 (3): 919-23
• The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, Kapp DS, Chan JK. Gynecol Oncol. 2006; 103 (3): 1095-9
• The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Hamilton CA, Cheung MK, Osann K, Balzer B, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. Gynecol Oncol. 2006; 103 (2): 679-83
• Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Cancer. 2006; 107 (8): 1823-30
• Uterine cancers. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N. J Natl Compr Canc Netw. 2006; 4 (5): 438-62
• Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK. Br J Cancer. 2006; 94 (5): 642-6
• A modified technique for insertion of intraperitoneal port for chemotherapy. Liou WS, Teng NN, Chan JK. J Surg Oncol. 2005; 90 (4): 247-8
• Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. Int J Radiat Oncol Biol Phys. 2005; 63 (3): 839-44
• Intraoperative radiation therapy in recurrent ovarian cancer. Yap OW, Kapp DS, Teng NN, Husain A. Int J Radiat Oncol Biol Phys. 2005; 63 (4): 1114-21
• B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies. Bhat NM, Bieber MM, Yang YC, Leu YS, van Vollenhoven RF, Teng NN. Hum Antibodies. 2004; 13 (3): 63-8
• Cervical cancer guidelines. Clinical practice guidelines in oncology. Teng N, Abu-Rustum NR, Bahador A, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Fiorica J, Greer BE, Kapp DS, Kavanagh J, Koh WJ, Kuettel M, Lurain JR, Molpus KL, Nag S, Partridge EE, Powell CB, Reynolds RK, Small W, Soper J, Tillmanns TD. J Natl Compr Canc Netw. 2004; 2 (6): 612-30
• Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Juretzka MM, Jensen KC, Longacre TA, Teng NN, Husain A. Gynecol Oncol. 2004; 93 (1): 107-11
• Differential expression of CD40 and CD95 in ovarian carcinoma. Ciaravino G, Bhat M, Manbeian CA, Teng NN. Eur J Gynaecol Oncol. 2004; 25 (1): 27-32
• Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Zang RY, Li ZT, Tang J, Cheng X, Cai SM, Zhang ZY, Teng NN. Cancer. 2004; 100 (6): 1152-61
• Preoperative CT diagnosis of primary fallopian tube carcinoma in a patient with a history of total abdominal hysterectomy. Santana P, Desser TS, Teng N. J Comput Assist Tomogr. 2003 May-Jun; 27 (3): 361-3
• Epoxidation of chiral camphor N-enoylpyrazolidinones with methyl(trifluoromethyl)dioxirane and urea hydrogen peroxide/acid anhydride: reversal of stereoselectivity. Fan CL, Lee WD, Teng NW, Sun YC, Chen K. J Org Chem. 2003; 68 (25): 9816-8
• Gene expression patterns in ovarian carcinomas. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI. Mol Biol Cell. 2003; 14 (11): 4376-86
• Modification of the vertical rectus abdominis musculocutaneous (VRAM) flap for functional reconstruction of complex vulvoperineal defects. Hui K, Zhang F, Pickus E, Rodriguez LF, Teng N, Lineaweaver WC. Ann Plast Surg. 2003; 51 (6): 556-60
• Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinoma. Huang GS, Juretzka M, Ciaravino G, Kohler S, Teng NN. Gynecol Oncol. 2002; 87 (3): 313-8
• VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype. Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM. J Rheumatol. 2002; 29 (10): 2114-21
• Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene. Bhat NM, Bieber MM, Young LW, Teng NN. Crit Rev Oncol Hematol. 2001 Jul-Aug; 39 (1-2): 59-68
• A new approach to enhancement of bone formation by electrically polarized hydroxyapatite. Teng NC, Nakamura S, Takagi Y, Yamashita Y, Ohgaki M, Yamashita K. J Dent Res. 2001; 80 (10): 1925-9
• Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats. da Paz LH, de Falco V, Teng NC, dos Reis LM, Pereira RM, Jorgetti V. Braz J Med Biol Res. 2001; 34 (8): 1015-22
• Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review. Ramos PC, Kapp DS, Longacre TA, Teng NN. Int J Gynecol Cancer. 2000; 10 (5): 429-434
• Primary leiomyosarcoma of the vagina. A case report and literature review. Ciaravino G, Kapp DS, Vela AM, Fulton RS, Lum BL, Teng NN, Roberts JA. Int J Gynecol Cancer. 2000; 10 (4): 340-347
• Recognition of auto- and exoantigens by V4-34 gene encoded antibodies. Bhat NM, Bieber MM, Spellerberg MB, Stevenson FK, Teng NN. Scand J Immunol. 2000; 51 (2): 134-40
• Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Smith RS, Kapp DS, Chen Q, Teng NN. Int J Radiat Oncol Biol Phys. 2000; 48 (3): 767-78
• Clinical practice guidelines in the management of gynecologic malignancies. Winn RJ, Teng NN. Hematol Oncol Clin North Am. 1999; 13 (1): 63-75, viii
• VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Albano SA, Teng NN. J Rheumatol. 1999; 26 (8): 1727-33
• Cytotoxicity of murine B lymphocytes induced by human VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Bhat NM, Bieber MM, Teng NN. Clin Immunol Immunopathol. 1997; 84 (3): 283-9
• Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodies. Bhat NM, Bieber MM, Teng NN. Hum Antibodies. 1997; 8 (3): 146-50
• Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. Bhat NM, Bieber MM, Hsu FJ, Chapman CJ, Spellerberg M, Stevenson FK, Teng NN. Clin Exp Immunol. 1997; 108 (1): 151-9
• Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma. Longacre TA, Hendrickson MR, Kapp DS, Teng NN. Gynecol Oncol. 1996; 63 (3): 404-10
• NCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer Network. Morgan RJ, Copeland L, Gershenson D, Locker G, McIntosh D, Ozols R, Teng N. Oncology (Williston Park). 1996; 10 (11 Suppl): 293-310
• Operative laparoscopy in the management of ovarian cancer. Amara DP, Nezhat C, Teng NN, Nezhat F, Nezhat C, Rosati M. Surg Laparosc Endosc. 1996; 6 (1): 38-45
• Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies. Markman M, Homesley H, Norberts DA, Schink J, Abbas F, Miller A, Soper J, Teng N, Hammond N, Muggia F, Israel M, Sweatman T. Gynecol Oncol. 1996; 61 (1): 90-3
• Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Bhat NM, Bieber MM, Stevenson FK, Teng NN. Clin Exp Immunol. 1996; 105 (1): 183-90
• The female genital tract. Longacre TA, Teng NN, Hendrickson MR. Pathology (Phila). 1996; 3 (2): 427-92
• VH4-34 (VH4.21) gene expression in the chronic arthritides of childhood: studies of associations with anti-lipid A antibodies, HLA antigens, and clinical features. Miller JJ, Bieber MM, Levinson JE, Zhu S, Tsou E, Teng NN. J Rheumatol. 1996; 23 (12): 2132-9
• Anti-endotoxin human monoclonal antibody A6H4C5 (HA-1A) utilizes the VH4.21 gene. Bieber MM, Bhat NM, Teng NN. Clin Infect Dis. 1995: 21 Suppl 2 S186-9
• Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy. Bhat NM, Mithal A, Bieber MM, Herzenberg LA, Teng NN. J Reprod Immunol. 1995; 28 (1): 53-60
• The role of laparoscopy in the management of gynecologic malignancy. Nezhat C, Nezhat F, Teng NN, Edraki B, Nezhat CH, Burrell MO, Benigno BB, Ramirez CE. Semin Surg Oncol. 1994 Nov-Dec; 10 (6): 431-9
• FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients. Reijnhart RM, Bieber MM, Teng NN. Immunobiology. 1994; 191 (1): 1-8
• Documentation of complete resolution of gestational choriocarcinoma in the oophorectomized patient. O'Hanlan KA, Wu TF, Teng NN. Gynecol Oncol. 1993; 51 (2): 261-5
• Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. Bhat NM, Bieber MM, Chapman CJ, Stevenson FK, Teng NN. J Immunol. 1993; 151 (9): 5011-21
• Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocytes. Rabin RL, Bieber MM, Teng NN. J Infect Dis. 1993; 168 (1): 135-42
• Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Mallipeddi P, Kapp DS, Teng NN. Cancer. 1993; 71 (10): 3076-81
• One-step enrichment of nucleated red blood cells. A potential application in perinatal diagnosis. Bhat NM, Bieber MM, Teng NN. J Immunol Methods. 1993; 158 (2): 277-80
• Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Eisenkop SM, Nalick RH, Wang HJ, Teng NN. Gynecol Oncol. 1993; 51 (2): 224-9
• Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium. Glasky MS, Yin A, Smith LH, Bieber M, Teng NN. Hum Antibodies Hybridomas. 1992; 3 (3): 114-22
• Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer. Miller DS, Spirtos NM, Ballon SC, Cox RS, Soriero OM, Teng NN. Cancer. 1992; 69 (2): 502-10
• Human monoclonal antibody recognizing an antigen associated with ovarian and other adenocarcinomas. Smith LH, Yin A, Glasky MS, Tyler N, Robles M, Foster CA, Bieber M, Teng NN. Am J Obstet Gynecol. 1992; 166 (2): 634-45
• The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Bhat NM, Kantor AB, Bieber MM, Stall AM, Herzenberg LA, Teng NN. Int Immunol. 1992; 4 (2): 243-52
• Gynecologic factors in sexual dysfunction of the older woman. Goldstein MK, Teng NN. Clin Geriatr Med. 1991; 7 (1): 41-61
• Modified posterior exenteration for ovarian cancer. Eisenkop SM, Nalick RH, Teng NN. Obstet Gynecol. 1991; 78 (5 Pt 1): 879-85
• Optical biosensor assay (OBA). Tsay YG, Lin CI, Lee J, Gustafson EK, Appelqvist R, Magginetti P, Norton R, Teng N, Charlton D. Clin Chem. 1991; 37 (9): 1502-5
• Quantitative protein changes in metastatic versus primary epithelial ovarian carcinoma. Lawson SR, Latter G, Miller DS, Goldstein D, Naps M, Burbeck S, Teng NN, Zuckerkandl E. Gynecol Oncol. 1991; 41 (1): 22-7
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. Ziegler EJ, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN. N Engl J Med. 1991; 324 (7): 429-36
• Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodies. Bhattacharjee AK, Sadoff JC, Collins H, Cross AS, Khalil AH, Bieber MM, Wright C, Teng NN. Bioconjug Chem. 1990 Nov-Dec; 1 (6): 375-80
• Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Christman JE, Teng NN, Lebovic GS, Sikic BI. Gynecol Oncol. 1990; 37 (2): 292-5
• Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans. Khazaeli MB, Wheeler R, Rogers K, Teng N, Ziegler E, Haynes A, Saleh MN, Hardin JM, Bolmer S, Cornett J. J Biol Response Mod. 1990; 9 (2): 178-84
• One step separation of human fetal lymphocytes from nucleated red blood cells. Bhat NM, Bieber MM, Teng NN. J Immunol Methods. 1990; 131 (1): 147-9
• Prospective randomized trial of topical alpha-interferon (alpha-interferon gels) for the treatment of vulvar intraepithelial neoplasia III. Spirtos NM, Smith LH, Teng NN. Gynecol Oncol. 1990; 37 (1): 34-8
• Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Christman JE, Miller DS, Coward P, Smith LH, Teng NN. Gynecol Oncol. 1990; 39 (1): 72-9
• Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. Taylor RN, Varma M, Teng NN, Roberts JM. J Clin Endocrinol Metab. 1990; 71 (6): 1675-7
• A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. McGuire WP, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT, Teng NN, Creasman WT. J Clin Oncol. 1989; 7 (10): 1462-8
• Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. Metoki R, Kakudo K, Tsuji Y, Teng N, Clausen H, Hakomori S. J Natl Cancer Inst. 1989; 81 (15): 1151-7
• Effects of anti-lipid A human monoclonal antibody on lipopolysaccharide-induced toxicity to the kidney. Tune BM, Hsu CY, Bieber MM, Teng NN. J Urol. 1989; 141 (6): 1463-6
• Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. Spirtos NM, Doshi BP, Kapp DS, Teng N. Gynecol Oncol. 1989; 35 (1): 20-6
• Topical interferon for treating condyloma acuminata in women. Keay S, Teng N, Eisenberg M, Story B, Sellers PW, Merigan TC. J Infect Dis. 1988; 158 (5): 934-9
• Cardiovascular effect of intravenous lipid A in rabbits. Ali KH, Feeley TW, Bieber M, McGrath B, Teng NN. Circ Shock. 1987; 23 (4): 285-93
• Clinical applications of monoclonal antibodies in gynecologic oncology. Smith LH, Teng NN. Cancer. 1987; 60 (8 Suppl): 2068-74
• Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes. Smith LH, Yin A, Bieber M, Teng NN. J Immunol Methods. 1987; 105 (2): 263-73
• Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Petrilli ES, Twiggs LB, Blessing JA, Teng NH, Curry S. Cancer. 1987; 60 (9): 2173-6
• The effect of human antiendotoxin monoclonal antibodies on endotoxin-induced lung injury in the rat. Feeley TW, Minty BD, Scudder CM, Jones JG, Royston D, Teng NN. Am Rev Respir Dis. 1987; 135 (3): 665-70
• A critical reassessment of second-look laparotomy in epithelial ovarian carcinoma. Miller DS, Ballon SC, Teng NN, Seifer DB, Soriero OM. Cancer. 1986; 57 (3): 530-5
• Epithelial ovarian carcinoma in patients with intersex disorders: the role of pituitary gonadotropins in ovarian tumorigenesis. Miller DS, Teng NN, Ballon SC. Gynecol Oncol. 1986; 24 (3): 299-308
• Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies. Campbell M, Bieber M, Levy R, Teng NN. J Immunol. 1986; 136 (8): 2983-8
• Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Rothbard JB, Fernandez R, Wang L, Teng NN, Schoolnik GK. Proc Natl Acad Sci U S A. 1985; 82 (3): 915-9
• Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Teng NN, Kaplan HS, Hebert JM, Moore C, Douglas H, Wunderlich A, Braude AI. Proc Natl Acad Sci U S A. 1985; 82 (6): 1790-4
• Partial hydatidiform mole with diploid karyotype: report of three cases. Teng NN, Ballon SC. Am J Obstet Gynecol. 1984; 150 (8): 961-4
• Production of human monoclonal IgG antibodies against Rhesus (D) antigen. Bron D, Feinberg MB, Teng NN, Kaplan HS. Proc Natl Acad Sci U S A. 1984; 81 (10): 3214-7
• Second-look laparotomy in epithelial ovarian carcinoma: precise definition, sensitivity, and specificity of the operative procedure. Ballon SC, Portnuff JC, Sikic BI, Turbow MM, Teng NN, Soriero OM. Gynecol Oncol. 1984; 17 (2): 154-60
• Somatic cell hybrid selection with a transfectable dominant marker. Riera FC, Blam SB, Teng NN, Kaplan HS. Somat Cell Mol Genet. 1984; 10 (2): 123-7
• Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Teng NN, Lam KS, Calvo Riera F, Kaplan HS. Proc Natl Acad Sci U S A. 1983; 80 (23): 7308-12
• Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia. Wu T, Ballon SC, Teng NN. Am J Obstet Gynecol. 1983; 147 (7): 821-5
• Characterization of an alpha-bungarotoxin binding component from Drosophila melanogaster. Schmidt-Nielsen BK, Gepner JI, Teng NN, Hall LM. J Neurochem. 1977; 29 (6): 1013-29
• Appearance of acetylcholine receptors in cultured myoblasts prior to fusion. Teng NN, Fiszman MY. J Supramol Struct. 1976; 4 (3): 381-7
• Mitogenicity of thrombin and surface alterations on mouse splenocytes. Chen LB, Teng NN, Buchanan JM. Exp Cell Res. 1976; 101 (1): 41-6
• Thrombin-sensitive surface protein of cultured chick embryo cells. Teng NN, Chen LB. Nature. 1976; 259 (5544): 578-80
• The role of surface proteins in cell proliferation as studied with thrombin and other proteases. Teng NN, Bo Chen L. Proc Natl Acad Sci U S A. 1975; 72 (2): 413-7
• Histones of chick embryonic lens nuclei. Teng NH, Piatigorsky J, Ingram VM. Dev Biol. 1974; 41 (1): 72-6
• Mechanism of action of p-hydroxybenzoate hydroxylase from Pseudomonas putida. 3. The enzyme-substrate complex. Teng N, Kotowycz G, Calvin M, Hosokawa K. J Biol Chem. 1971; 246 (17): 5448-53
• The 220 MHz nuclear magnetic resonance study of a solvent-induced conformational change in flavin adenine dinucleotide. Kotowycz G, Teng N, Klein MP, Calvin M. J Biol Chem. 1969; 244 (20): 5656-62
• [PRELIMINARY STUDIES ON LIGHT ANESTHESIA WITH ETHER]. TENG NF, WANG LH, CHANG KH. Zhonghua Wai Ke Za Zhi. 1963: 11 802-4
• Poisoning: a four year survey. DOBSON HL, DAESCHNER CW, MONDSHINE R, TENG N, PREBLE H, KNUDSEN JM. Tex State J Med. 1957; 53 (7): 514-9